TIL（肿瘤浸润淋巴细胞）与 II 期和 III 期结直肠癌生存的关联

The tumor microenvironment is crucial in tumourigenesis, response to therapy, and elimination of tumor cells. Tumor-infiltrating lymphocytes (TILs) promote the host immune response and are associated with a better prognosis in colorectal cancer (CRC). This multicentric retrospective study evaluated the relationship between the presence and intensity of TILs and survival outcomes. A total of 651 patients from four Portuguese oncological centers who underwent surgical resection for stages II or III colorectal adenocarcinoma between 2016 and 2019 were included in this study. The mean age of the study population was 70 years; 58. 2% were males. The median overall survival was 58. 03 ± 1. 29 months (95% confidence interval (CI) 55.

50 - 60. 56), and the median disease-free survival (DFS) was 53. 02 ± 1. 39 months (95% CI 50. 29 - 55. 74). Patients with high infiltrate (including those with moderate, abundant, or Crohn-like infiltrate) had significantly longer DFS i. e. , 58. 48 ± 1. 84 months (95% CI 54. 87 - 62. 09 months) vs 49. 22 ± 1. 75 months (95% CI 45. 79 - 52.

64 months) in the group with absent or minimal infiltrate; p = 0. 003. Assessing the side of the tumor, high infiltrate was associated with higher DFS (59. 86 ± 2. 36 months (95% CI 55. 23 - 64. 50 months) vs 49. 60 ± 2. 40 months (95% CI 44. 90 - 54. 29 months), p = 0. 011). This work reinforces the importance of research into possible prognostic and predictive factors in patients with CRC.